H. D. Smith makes changes to executive leadership structure

Dale Smith, chairman and CEO of H. D. Smith Holding Co.

SPRINGFIELD, Ill. — H. D. Smith, an independent wholesaler and pharmaceutical brand support company, has announced a series of executive moves, including the appointment of Dale Smith as chairman and CEO of H. D. Smith Holding Co.

In his new role, Smith will oversee progress for all H. D. Smith business units, including wholesale distribution and specialty solutions. Smith previously served as chairman and CEO of H. D. Smith Wholesale Drug Co.



Additional executive moves include:

• 
  Chris Smith, who served as president and COO for H. D. Smith Wholesale Drug Co., is now its president and CEO, with executive responsibility for the H. D. Smith wholesale distribution business unit, as well as the functional areas of information technology, human resources and finance, which support the entire company.


• 
  Bob Appleby, previously SVP of category management at H. D. Smith Wholesale Drug Co., has been named president of H. D. Smith Specialty Solutions, which includes subsidiaries Smith Medical Partners and Triplefin. Transitioning into this role, he will be responsible for managing one of the company's fastest-growing business units as the nation seeks to shift health delivery closer to patients.


• 
  Joe Conda joins the office of the chairman as EVP to focus on expanding upon the company's mission as an integrated provider of health products, solutions and services, a role that includes acquisitions and alliances. He was previously president of H. D. Smith Specialty Solutions.